Navigation Links
The Case for Trial Lawyers
Date:7/8/2008

and in pulling dangerous drugs off the market.

Do you believe that the understaffed and overwhelmed FDA, which until recently believed lawsuits were an essential additional safety check, should be the sole judge of whether foods, drugs and medical devices are safe for you?

Tell that to the more than 3,000 women and their families who have sued Johnson & Johnson alleging that its Ortho Evra birth-control patch had caused heart attacks, strokes and even death. Rather than delivering less estrogen than a standard daily birth control pill, as the FDA-approved label indicated, the patch actually delivered more and increased the risk of blood clots. Johnson & Johnson, based on its own studies, knew that -- but delayed telling the FDA and the public.

Or tell the hundreds mostly dialysis patients who suffered allergic reactions, including several who died, after taking an apparently tainted blood thinner, heparin. The manufacturer withdrew the drug earlier this year after questions arose about its Chinese supplier -- which apparently had never been inspected by the FDA.

Meanwhile, in Pennsylvania, tort reform -- including proposals to place caps on non-medical damages -- continues to be a popular topic. But, with lawsuits against Pennsylvania doctors declining 38 percent between 2003 and 2006, the medical malpractice crisis in Pennsylvania is over in Gov. Rendell's view. One reason for the decline: a certificate of merit requirement that prevents malpractice lawsuits from proceeding unless a licensed doctor signs off on the validity of the claim. Nonetheless, even though the Institute on Medicine says nearly 100,000 die as a result of medical mistakes each year, hospitals are lobbying to completely shield their doctors from lawsuits.

Trial lawyers strongly endorse legislation that quashes frivolous lawsuits. But if you believe that legitimate litigation plays a crucial role in protecting patients and consumers, let your state and federal l
'/>"/>

SOURCE Saltz, Mongeluzzi, Barrett & Bendesky P.C.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New clinical trial for patients with asbestos-associated lung cancer
2. Austin Company Makes a Splash at U.S. Olympic Team Swimming Trials
3. Blood Substitute Found Safe in Large Phase III Trial
4. The Montreal Heart Institute presents findings on congestive heart failure and atrial fibrillation
5. Evalve MitraClip: Clinical trial of nonsurgical repair for severe mitral valve regurgitation
6. Molecular insight begins Trofex Phase 1 trial for detection of metastatic prostate cancer
7. New insight into RA patient priorities and motivators for clinical trial involvement
8. Molecular insight begins Trofex Ph. 1 trial for detection of metastatic prostate cancer
9. Industrial Control Repair Named Honda of America Manufacturings 2007 Supplier of the Year
10. Organizers of cancer clinical trials are neglecting teenagers and young adults
11. Bradmer receives FDA approval to proceed with Phase III clinical trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2015)... 2015 The federal court overseeing ... pending in the U.S. District Court, Northern District ... Management Conference for April 21st at 1:30 p.m. ... the progress of product liability claims filed on ... strokes and other cardiovascular complications due to their ...
(Date:3/29/2015)... 2015 “Health is an endo thing, ... learn more about the cannabinoid system … we learn ... Publius’ Go Endo-Cannabinoid Update ~ new on the ... celebrated. Publius, of The Cannabis Papers: A citizen’s guide ... Health (PubMed) cannabinoid system (CS) articles discussing: cannabinoids in ...
(Date:3/28/2015)... March 28, 2015 Take a bite ... kicks into action. Acids tumble into the stomach, ready ... faulty valve-like structure lets these acids run amok, triggering ... extremely common symptom. More than 60 million Americans have ... examine where heartburn starts, and how it can be ...
(Date:3/28/2015)... 2015 India Network visitor health ... available to all visitors who purchase the plan before ... are encouraged to purchase the insurance program as soon ... proper coverage for pre-existing medical conditions. Parents and grandparents ... medical conditions with serious consequences to their health. Many ...
(Date:3/28/2015)... Las Vegas, NV (PRWEB) March 28, 2015 ... hip injuries is a growing field in orthopaedic medicine. ... with labral tear to confirm the pain etiology, research ... Medicine’s ( AOSSM ) Specialty Day suggests that pain ... outcomes following arthroscopic hip surgery. , “Our study ...
Breaking Medicine News(10 mins):Health News:Federal Court Overseeing Testosterone Treatment Lawsuits Schedules April Case Management Conference 2Health News:Federal Court Overseeing Testosterone Treatment Lawsuits Schedules April Case Management Conference 3Health News:March Homeostasis: Publius’ Go Endo-Cannabinoid Update ~ New on the Bryan William Brickner Blog 2Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2
... CHAPEL HILL, N.C., April 18 Sales leaders ... services offered by,Best Practices, LLC and in particular ... the Best Practice Database., (http://www.BestPracticeDatabase.com ) Although documents ... many sales leaders have come to find,outstanding value ...
... WASHINGTON, April 18 The following is being,issued ... and Coalition of Full Service Community Hospitals:, ... and the,conflict of interest it creates between a ... fact, over the last year, the House of,Representatives ...
... LeMaitre,Vascular, Inc. (Nasdaq: LMAT ) announced today ... on April 30, 2008, after the close of the,market. ... be hosted,the same day at 5:00 PM ET. The ... participants may listen to the live webcast at, http://www.lemaitre.com/investor, ...
... much as drug treatments , , FRIDAY, April 18 (HealthDay ... in patients with terminal cancer, according to Japanese researchers ... a total of 517 patients with incurable cancer and ... for these patients was supportive expressive group therapy, in ...
... Masimo CEO and CFO to begin after markets ... close at 2:00 p.m. PT (5:00 p.m. ET), ... the inventor of Pulse CO-Oximetry and,Measure-Through-Motion-and-Low-Perfusion pulse oximetry, today announced it,will ... after the market closes on Tuesday, April 29, 2008., A ...
... Benefit Sharp Rehabilitation Services -, SAN DIEGO, ... will hold its second annual charity event, a ... in Point Loma on June 20th and,21st. More ... throughout California are,expected to participate. This year, representatives ...
Cached Medicine News:Health News:Sales Executives Finding Value in Best Practice Database 2Health News:Statement: Congress Should Include the Physician Self-Referral Provision in the Farm Bill for Patients and Communities 2Health News:Talk Therapy Proves Effective for Terminal Cancer Patients 2Health News:Masimo to Report First Quarter 2008 Financial Results on April 29, 2008 2
(Date:3/27/2015)... March 27, 2015  Victoria Vein & Surgery Clinic is ... Astanza Duality laser in Victoria, Texas . ... well as advanced laser treatments for a variety of medical ... industry to provide more services for their patients. Since adding ... Victoria residents get rid of their ...
(Date:3/27/2015)... 27, 2015 A new report from Kalorama Information ... – Chile , Colombia ... targets for IVD firms.  The healthcare research firm said that ... strategies for the Latin American continent with a population of ... supply operations. However, the country,s regional economic clout does not ...
(Date:3/27/2015)... March 27, 2015 XRpro Sciences, Inc., ... discovery and development services which features high throughput ... industry, announced financial results for the year ended ...  Tyson, Chairman of XRpro Sciences commented, "We have ... from development stage to commercial stage in large ...
Breaking Medicine Technology:Victoria Vein And Surgery Clinic Uses Advanced Astanza Duality Tattoo Removal Technology 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4
... , SAN DIEGO, Dec. 21 ... their highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor, ... The first trial in human subjects, NBI-98854-0801, was a ... in Canada under an approved Clinical Trial Application (CTA) ...
... , CARLSBAD, Calif., Dec. 21 Isis Pharmaceuticals, Inc. ... a $10 million payment from OncoGenex Pharmaceuticals, Inc. (Nasdaq: ... OGX-011 to Teva Pharmaceutical Industries Ltd. ( TEVA). OGX-011 ... that has completed a successful Phase 2 program in patients ...
Cached Medicine Technology:Neurocrine Advances VMAT2 Inhibitor Program 2Neurocrine Advances VMAT2 Inhibitor Program 3Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 to Teva 2Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 to Teva 3
These backbiters enable simple access to the anterior horn of the meniscus....
The narrow shaft and compact jaw design facilitates access and use in tight spaces, particularly useful in the posterior aspect of the knee....
... Hand Instruments were developed in surgeon's desire ... still having an instrument with the strength ... fear of the bending or breaking. Arthrotek ... to conform to the surgeon's hand. This ...
... Instruments were developed in surgeon's desire to ... having an instrument with the strength to ... of the bending or breaking. Arthrotek Hand ... conform to the surgeon's hand. This new ...
Medicine Products: